6:08 PM
 | 
Jan 30, 2013
 |  BC Extra  |  Company News

Genzyme's Kynamro to cost $176,000 annually

Genzyme Corp. said hypercholesterolemia drug Kynamro mipomersen will cost about $3,380 per weekly injection, or about $176,000 annually. FDA approved the drug late Tuesday as an addition...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >